Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function, causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death.
The main symptoms of this condition appears in childhood and includes delay of motor functions; progressive muscle weakness; muscle contractures in legs; and muscle weakness in arms, neck, and more severely in the lower half of the body. The bones also develop peculiarly, causing skeletal deformities in the patient. Occurrences of pseudo-hypertrophy, cardiomyopathy, and breathing complications are some of the other symptoms of this condition.
This report elaborates on the current development of the Duchenne Muscular Dystrophy Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Biophytis SAS
Sarepta Therapeutics Inc
GTx Inc
Debiopharm International SA
F Hoffmann-La Roche Ltd
SOM Biotech SL
Genethon SA
FibroGen Inc
Akashi Therapeutics Inc
Catabasis Pharmaceuticals Inc
Strykagen Corp
CRISPR Therapeutics
Cumberland Pharmaceuticals Inc
Bioleaders Corp
Biogen Inc
Galapagos NV
Taiho Pharmaceutical Co Ltd
Fulcrum Therapeutics Inc
Editas Medicine Inc
Santhera Pharmaceuticals Holding AG
WAVE Life Sciences Ltd
BioMarin Pharmaceutical Inc
Summit Therapeutics Plc
Daiichi Sankyo Co Ltd
Eloxx Pharmaceuticals Inc
Teijin Pharma Ltd
Beech Tree Labs Inc
Capricor Therapeutics Inc
Antisense Therapeutics Ltd
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Development & Drug Target
Mechanism of Action (MoA)
Route of Administration (RoA)
Molecule Type
Application:
Hospitals and Clinics
Medical Laboratories
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Duchenne Muscular Dystrophy Drugs Industry Overview
-
1.1.1 Duchenne Muscular Dystrophy Drugs Market Scope and Market Segments
-
1.1.2 Duchenne Muscular Dystrophy Drugs Industry Characteristics
-
1.1.3 Global and China Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Duchenne Muscular Dystrophy Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Development & Drug Target
-
1.2.2 Mechanism of Action (MoA)
-
1.2.3 Route of Administration (RoA)
-
1.2.4 Molecule Type
-
1.3 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals and Clinics
-
1.3.2 Medical Laboratories
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Duchenne Muscular Dystrophy Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Duchenne Muscular Dystrophy Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Duchenne Muscular Dystrophy Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Duchenne Muscular Dystrophy Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Duchenne Muscular Dystrophy Drugs Industry PEST Analysis
-
2.3 Duchenne Muscular Dystrophy Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Duchenne Muscular Dystrophy Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Duchenne Muscular Dystrophy Drugs Industry
Chapter 3 Global and China Duchenne Muscular Dystrophy Drugs Market, by Manufacturer
-
3.1 Global and China Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Duchenne Muscular Dystrophy Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Duchenne Muscular Dystrophy Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Duchenne Muscular Dystrophy Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Duchenne Muscular Dystrophy Drugs Market Top 3 Players
Chapter 4 Global and China Duchenne Muscular Dystrophy Drugs Market, by Type (2017-2028)
-
4.1 Duchenne Muscular Dystrophy Drugs Market Trend, by Type
-
4.2 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Duchenne Muscular Dystrophy Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Duchenne Muscular Dystrophy Drugs Price Trend, by Type (2017-2028)
-
4.3 China Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Duchenne Muscular Dystrophy Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Duchenne Muscular Dystrophy Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Duchenne Muscular Dystrophy Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Duchenne Muscular Dystrophy Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Duchenne Muscular Dystrophy Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Duchenne Muscular Dystrophy Drugs Market Analysis
-
7.1 North America Duchenne Muscular Dystrophy Drugs Market, by Type
-
7.2 North America Duchenne Muscular Dystrophy Drugs Market, by Application
-
7.3 North America Duchenne Muscular Dystrophy Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Duchenne Muscular Dystrophy Drugs Market Analysis
-
8.1 Europe Duchenne Muscular Dystrophy Drugs Market, by Type
-
8.2 Europe Duchenne Muscular Dystrophy Drugs Market, by Application
-
8.3 Europe Duchenne Muscular Dystrophy Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Duchenne Muscular Dystrophy Drugs Market Analysis
-
9.1 APAC Duchenne Muscular Dystrophy Drugs Market, by Type
-
9.2 APAC Duchenne Muscular Dystrophy Drugs Market, by Application
-
9.3 APAC Duchenne Muscular Dystrophy Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Duchenne Muscular Dystrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Duchenne Muscular Dystrophy Drugs Company Profiles
-
11.1 Biophytis SAS
-
11.1.1 Biophytis SAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Biophytis SAS Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.1.3 Biophytis SAS Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Sarepta Therapeutics Inc
-
11.2.1 Sarepta Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Sarepta Therapeutics Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.2.3 Sarepta Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 GTx Inc
-
11.3.1 GTx Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 GTx Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.3.3 GTx Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Debiopharm International SA
-
11.4.1 Debiopharm International SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Debiopharm International SA Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.4.3 Debiopharm International SA Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 F Hoffmann-La Roche Ltd
-
11.5.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 F Hoffmann-La Roche Ltd Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.5.3 F Hoffmann-La Roche Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 SOM Biotech SL
-
11.6.1 SOM Biotech SL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 SOM Biotech SL Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.6.3 SOM Biotech SL Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Genethon SA
-
11.7.1 Genethon SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Genethon SA Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.7.3 Genethon SA Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 FibroGen Inc
-
11.8.1 FibroGen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 FibroGen Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.8.3 FibroGen Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Akashi Therapeutics Inc
-
11.9.1 Akashi Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.9.3 Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Catabasis Pharmaceuticals Inc
-
11.10.1 Catabasis Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.10.3 Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Strykagen Corp
-
11.11.1 Strykagen Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Strykagen Corp Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.11.3 Strykagen Corp Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 CRISPR Therapeutics
-
11.12.1 CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.12.3 CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Cumberland Pharmaceuticals Inc
-
11.13.1 Cumberland Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Cumberland Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.13.3 Cumberland Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Bioleaders Corp
-
11.14.1 Bioleaders Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Bioleaders Corp Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.14.3 Bioleaders Corp Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Biogen Inc
-
11.15.1 Biogen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Biogen Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.15.3 Biogen Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Galapagos NV
-
11.16.1 Galapagos NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Galapagos NV Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.16.3 Galapagos NV Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Taiho Pharmaceutical Co Ltd
-
11.17.1 Taiho Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Taiho Pharmaceutical Co Ltd Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.17.3 Taiho Pharmaceutical Co Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Fulcrum Therapeutics Inc
-
11.18.1 Fulcrum Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Fulcrum Therapeutics Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.18.3 Fulcrum Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Editas Medicine Inc
-
11.19.1 Editas Medicine Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Editas Medicine Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.19.3 Editas Medicine Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.20 Santhera Pharmaceuticals Holding AG
-
11.20.1 Santhera Pharmaceuticals Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.20.2 Santhera Pharmaceuticals Holding AG Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.20.3 Santhera Pharmaceuticals Holding AG Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.21 WAVE Life Sciences Ltd
-
11.21.1 WAVE Life Sciences Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.21.2 WAVE Life Sciences Ltd Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.21.3 WAVE Life Sciences Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.22 BioMarin Pharmaceutical Inc
-
11.22.1 BioMarin Pharmaceutical Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.22.2 BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.22.3 BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.23 Summit Therapeutics Plc
-
11.23.1 Summit Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.23.2 Summit Therapeutics Plc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.23.3 Summit Therapeutics Plc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.24 Daiichi Sankyo Co Ltd
-
11.24.1 Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.24.2 Daiichi Sankyo Co Ltd Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.24.3 Daiichi Sankyo Co Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.25 Eloxx Pharmaceuticals Inc
-
11.25.1 Eloxx Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.25.2 Eloxx Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.25.3 Eloxx Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.26 Teijin Pharma Ltd
-
11.26.1 Teijin Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.26.2 Teijin Pharma Ltd Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.26.3 Teijin Pharma Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.27 Beech Tree Labs Inc
-
11.27.1 Beech Tree Labs Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.27.2 Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.27.3 Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.28 Capricor Therapeutics Inc
-
11.28.1 Capricor Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.28.2 Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.28.3 Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.29 Antisense Therapeutics Ltd
-
11.29.1 Antisense Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.29.2 Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
-
11.29.3 Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Duchenne Muscular Dystrophy Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Duchenne Muscular Dystrophy Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Duchenne Muscular Dystrophy Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Development & Drug Target (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Mechanism of Action (MoA) (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Route of Administration (RoA) (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Molecule Type (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Hospitals and Clinics (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Medical Laboratories (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Duchenne Muscular Dystrophy Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Duchenne Muscular Dystrophy Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Duchenne Muscular Dystrophy Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Duchenne Muscular Dystrophy Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Duchenne Muscular Dystrophy Drugs Market Share, by Manufacturer in 2022
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume, by Type (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Value, by Type (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Price Trend, by Type (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Volume, by Type (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Value, by Type (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Price Trend, by Type (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume, by Application (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Value, by Application (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Duchenne Muscular Dystrophy Drugs Sales Value Share, by Application (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Volume, by Application (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Value, by Application (2017-2028)
-
Table China Duchenne Muscular Dystrophy Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Duchenne Muscular Dystrophy Drugs Sales Volume, by Type (2017-2028)
-
Table North America Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Duchenne Muscular Dystrophy Drugs Sales Volume, by Application (2017-2028)
-
Table North America Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Duchenne Muscular Dystrophy Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Duchenne Muscular Dystrophy Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Duchenne Muscular Dystrophy Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Duchenne Muscular Dystrophy Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Duchenne Muscular Dystrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table Biophytis SAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biophytis SAS Product Profiles, Application and Specification
-
Table Biophytis SAS Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sarepta Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sarepta Therapeutics Inc Product Profiles, Application and Specification
-
Table Sarepta Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GTx Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GTx Inc Product Profiles, Application and Specification
-
Table GTx Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Debiopharm International SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Debiopharm International SA Product Profiles, Application and Specification
-
Table Debiopharm International SA Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification
-
Table F Hoffmann-La Roche Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SOM Biotech SL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SOM Biotech SL Product Profiles, Application and Specification
-
Table SOM Biotech SL Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genethon SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genethon SA Product Profiles, Application and Specification
-
Table Genethon SA Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table FibroGen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table FibroGen Inc Product Profiles, Application and Specification
-
Table FibroGen Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Akashi Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Akashi Therapeutics Inc Product Profiles, Application and Specification
-
Table Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Catabasis Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Catabasis Pharmaceuticals Inc Product Profiles, Application and Specification
-
Table Catabasis Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Strykagen Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Strykagen Corp Product Profiles, Application and Specification
-
Table Strykagen Corp Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CRISPR Therapeutics Product Profiles, Application and Specification
-
Table CRISPR Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cumberland Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cumberland Pharmaceuticals Inc Product Profiles, Application and Specification
-
Table Cumberland Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bioleaders Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bioleaders Corp Product Profiles, Application and Specification
-
Table Bioleaders Corp Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biogen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Inc Product Profiles, Application and Specification
-
Table Biogen Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Galapagos NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Galapagos NV Product Profiles, Application and Specification
-
Table Galapagos NV Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Taiho Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Taiho Pharmaceutical Co Ltd Product Profiles, Application and Specification
-
Table Taiho Pharmaceutical Co Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Fulcrum Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Fulcrum Therapeutics Inc Product Profiles, Application and Specification
-
Table Fulcrum Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Editas Medicine Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Editas Medicine Inc Product Profiles, Application and Specification
-
Table Editas Medicine Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Santhera Pharmaceuticals Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Santhera Pharmaceuticals Holding AG Product Profiles, Application and Specification
-
Table Santhera Pharmaceuticals Holding AG Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table WAVE Life Sciences Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table WAVE Life Sciences Ltd Product Profiles, Application and Specification
-
Table WAVE Life Sciences Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioMarin Pharmaceutical Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioMarin Pharmaceutical Inc Product Profiles, Application and Specification
-
Table BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Summit Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Summit Therapeutics Plc Product Profiles, Application and Specification
-
Table Summit Therapeutics Plc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Daiichi Sankyo Co Ltd Product Profiles, Application and Specification
-
Table Daiichi Sankyo Co Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eloxx Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eloxx Pharmaceuticals Inc Product Profiles, Application and Specification
-
Table Eloxx Pharmaceuticals Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teijin Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teijin Pharma Ltd Product Profiles, Application and Specification
-
Table Teijin Pharma Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Beech Tree Labs Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Beech Tree Labs Inc Product Profiles, Application and Specification
-
Table Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Capricor Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Capricor Therapeutics Inc Product Profiles, Application and Specification
-
Table Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Antisense Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Antisense Therapeutics Ltd Product Profiles, Application and Specification
-
Table Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
